Boric acid

General characteristics. Structure:

Active ingredient: 300 mg of boric acid in 1 bottle.

Excipient: alcohol of ethyl 70%.

Pharmacological properties:

The antiseptic agent, renders also insecticidal (including protivopedikulezny) action. Coagulates proteins (including fermental) a microbic cell, breaks permeability of a cellular cover. 5% aqueous solution suppress processes of phagocytosis, 2-4% solution detain growth and development of bacteria. Possesses irritant action on mucous membranes, granulyatsionny fabrics. Being soaked up, renders system toxic effects.

Pharmacokinetics. Well gets through skin and mucous membranes; it is slowly removed and can collect in bodies and fabrics. The rest within 5-7 days is removed by kidneys In 50% (during 12 h).

Indications to use:

Acute, chronic outside and average otitis without injury of a tympanic membrane.

Route of administration and doses:

Locally. At acute and chronic otitis of 3-5 drops apply on a turunda and enter into outside acoustical pass 2-3 times a day.

The course of treatment should not exceed 3-5 days.

Features of use:

To avoid drawing on mucous membranes and on extensive body surfaces.

Pregnancy and lactation. External use of medicine is contraindicated for pregnant women and the nursing women.

Use at children's age: contraindicated.

Influence on a possibility of control of vehicles and works with dangerous devices and mechanisms. Does not influence.

Side effects:

Local reactions: itch, burning, dermahemia of outside acoustical pass. Allergic reactions.

Interaction with other medicines:

At simultaneous use with drugs for external use new connections with unexpected effect can be created.

Contraindications:

Hypersensitivity to boric acid, a chronic renal failure, acute inflammatory diseases of skin; pregnancy, children's age, perforation of a tympanic membrane, lactation period.

Overdose:

Intoxication symptoms (at accidental intake): nausea, vomiting, diarrhea, a gastralgia, disturbance of functions of cardiovascular system, stimulation or oppression of the central nervous system, a hyper pyrexia, erythematic rashes with the subsequent desquamation of an epithelium (the lethal outcome in 5-7 days), a renal failure and a liver (including jaundice is possible), a circulator collapse, shock, including with a lethal outcome.

Treatment: symptomatic. Hemotransfusion, haemo - and peritoneal dialysis.

Storage conditions:

At a temperature not above 25 ºC. To store in the place, unavailable to children. A period of validity - 3 years. Not to use medicine after the termination of a period of validity.

Issue conditions:

Without recipe

Packaging:

10 ml in a bottle, in packaging No. 1.